C
CABA icon

Covestor’s Cabaletta Bio CABA Stock Holding History

Covestor’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-34
Closed – – 2287
2025
Q4 		$0 Hold
34
– – ﹤0.01% 2290
2025
Q3 		$0 Hold
34
– – ﹤0.01% 2310
2025
Q2 		$0 Sell
34
-3
-8% -$5 ﹤0.01% 2234
2025
Q1 		$0 Buy
37
+25
+208% +$53 ﹤0.01% 2247
2024
Q4 		$0 Buy
12
+1
+9% +$4 ﹤0.01% 2259
2024
Q3 		$0 Buy
11
+7
+175% +$41 ﹤0.01% 2244
2024
Q2 		$0 Hold
4
– – ﹤0.01% 2259
2024
Q1 		$0 Buy
+4
New +$86 ﹤0.01% 2260

Other funds holding CABA

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Covestor's CABA Position: Q1 2026 in Review

Covestor sold out of Cabaletta Bio (CABA) in Q1 2026, closing a stake of 34 shares.

Covestor first reported a position in CABA in Q1 2024 and held it in 8 quarters. The position peaked at $0 in Q4 2025. 108 funds tracked by Wall St. Rank hold CABA as of Q1 2026.

  • Covestor reported no remaining Cabaletta Bio position as of Q1 2026 after selling out during the quarter.
  • Covestor sold 34 Cabaletta Bio shares in Q1 2026.
  • Covestor first reported a position in Cabaletta Bio in Q1 2024 and held it in 8 quarters.
  • Covestor's Cabaletta Bio position peaked at $0 in Q4 2025.
  • 108 funds tracked by Wall St. Rank held Cabaletta Bio as of Q1 2026.

Based on Covestor's 13F filing for Q1 2026, filed 5 May 2026.